CancerX Announces Steering Committee and Strategic Priorities
BOSTON, Sept. 12, 2023 /PRNewswire/ -- CancerX, the public-private partnership that launched in March of this year to harness the power of innovation to help achieve the goals of the Cancer Moonshot, announced its inaugural steering committee and strategic priorities. CancerX is co-hosted by the Digital Medicine Society (DiMe) and Moffitt Cancer Center alongside the Office of the National Coordinator for Health Information Technology (ONC) and the Office of the Assistant Secretary for Health (OASH).
- BOSTON, Sept. 12, 2023 /PRNewswire/ -- CancerX, the public-private partnership that launched in March of this year to harness the power of innovation to help achieve the goals of the Cancer Moonshot, announced its inaugural steering committee and strategic priorities.
- CancerX is unmatched in convening leading innovators from across the country," said Mary Tolikas, PhD, MBA, SVP & Chief Innovation Officer, Dana-Farber Cancer Institute.
- Representatives from over 125 CancerX member organizations also joined The White House officials and representatives from across the federal government to set strategic priorities and outline activities for CancerX that align with and augment the broader Cancer Moonshot community.
- The group set the following strategic priorities for Year 1 of CancerX:
Demonstrate CancerX as the global leader in advancing digital innovation in oncology in alignment with the goals of the reignited Cancer Moonshot.